The proprietary BluePath Score dashboard integrates wearable data, DNA methylation testing, and gut microbiome analysis into a single healthspan metric
Priority: Establish consistent administration habits
This may seem like a small difference, but it greatly impacts the drugs effect on weight and blood sugar control
And by educating patients on both the benefits and risks, we can help them become more alert and attuned to their GI symptoms even before they start this medication. Advertisement Advertisement A new study shows that an AI-enabled bundled system of sensors and coaching reduced A1C with fewer medications TRANSITION-T2D RCT results for patients with T2D receiving MDI Large retrospective analysis may prompt prospective studies Robust signal from observational study raises prospect of a long-sought medical therapy Post hoc analysis of SURPASS-CVOT trial has implications for future cardiovascular outcome trials Retrospective analysis finds lower mortality rates, fewer hospital visits among patients with Type 1 diabetes using GLP-1 Therapies Emerging evidence suggests a patient-specific approach Looking at the real-world impact and the future pipeline of targeted therapies
IV infusions cost between 890 to 1290 per infusion per week, adding up to over 50,000 AUD per year
GH has dropped enough to produce symptoms, but enough pituitary responsiveness remains for strong clinical results during this window